These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9544741)

  • 41. Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
    Calkin AC; Lee SD; Kim J; Van Stijn CM; Wu XH; Lusis AJ; Hong C; Tangirala RI; Tontonoz P
    Circ Res; 2014 Aug; 115(4):442-9. PubMed ID: 24935961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of lipoprotein receptors in atherosclerotic lesions.
    Hiltunen TP; Ylä-Herttuala S
    Atherosclerosis; 1998 Apr; 137 Suppl():S81-8. PubMed ID: 9694546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
    Gosling J; Slaymaker S; Gu L; Tseng S; Zlot CH; Young SG; Rollins BJ; Charo IF
    J Clin Invest; 1999 Mar; 103(6):773-8. PubMed ID: 10079097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Class A scavenger receptors, macrophages, and atherosclerosis.
    Linton MF; Fazio S
    Curr Opin Lipidol; 2001 Oct; 12(5):489-95. PubMed ID: 11561167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE.
    Kowala MC; Recce R; Beyer S; Gu C; Valentine M
    Atherosclerosis; 2000 Apr; 149(2):323-30. PubMed ID: 10729382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol-fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits.
    Daugherty A; Rateri DL
    Arterioscler Thromb; 1994 Dec; 14(12):2017-24. PubMed ID: 7526898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages.
    Sakai M; Miyazaki A; Hakamata H; Suginohara Y; Sakamoto YI; Morikawa W; Kobori S; Schichiri M; Horiuchi S
    Atherosclerosis; 1996 Jan; 119(2):191-202. PubMed ID: 8808496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
    Fan J; Ji ZS; Huang Y; de Silva H; Sanan D; Mahley RW; Innerarity TL; Taylor JM
    J Clin Invest; 1998 May; 101(10):2151-64. PubMed ID: 9593771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development.
    Van Eck M; Bos IS; Hildebrand RB; Van Rij BT; Van Berkel TJ
    Am J Pathol; 2004 Sep; 165(3):785-94. PubMed ID: 15331403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
    Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.
    Febbraio M; Podrez EA; Smith JD; Hajjar DP; Hazen SL; Hoff HF; Sharma K; Silverstein RL
    J Clin Invest; 2000 Apr; 105(8):1049-56. PubMed ID: 10772649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57Bl/6 mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1961-7. PubMed ID: 10938018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.